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Abstract 
An area of rapid advancement in abdominal MRI is diffusion-weighted imaging (DWI). By 
measuring diffusion properties of water molecules, DWI is capable of non-invasively probing 
tissue properties and physiology at cellular and macromolecular level. The integration of DWI as 
part of abdominal MRI exam allows better lesion characterization and therefore more accurate 
initial diagnosis and treatment monitoring. One of the most technical challenging, but also most 
useful abdominal DWI applications is in liver and therefore requires special attention and careful 
optimization. In this article, the latest technical developments of DWI and its liver applications are 
reviewed with the explanations of the technical principles, recommendations of the imaging 
parameters, and examples of clinical applications. More advanced DWI techniques, including 
Intra-Voxel Incoherent Motion (IVIM) diffusion imaging, anomalous diffusion imaging, and 
Diffusion Kurtosis Imaging (DKI) are discussed. 
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Introduction 
Diffusion-weighted imaging (DWI) is a noninvasive imaging technique sensitive to the mobility 
of water molecule at cellular and macromolecular level, much smaller than the scale of the spatial 
resolution or voxel size of the images [1, 2]. At such level, the motion of water is strongly 
influenced by the inter-cellular and intra-cellular environment which changes with tissue type and 
pathology. For example, for tissue or tumor with high cellularity, the movement of water molecule 
is more restricted because of narrower inter-cellular space. In addition, the diffusion weighted MRI 
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signal is sensitive to transport process such as the blood flow in the capillary vessels. The ability 
to probe tissue microstructure makes DWI a powerful tool in clinical diagnosis of abdominal 
diseases and differentiation of different types of lesions. In last few years, DWI has become of 
routine part of abdominal MRI [3].  
DWI has been found to be sensitive in detecting a variety of focal liver lesions including 
cholangiocarcinoma [4],  inflammatory myofibroblastic tumor (IMT) [5], intrahepatic bile duct 
adenoma (BDA) [2], hepatocellular carcinoma (HCC) [6-8], hemangioma [9], focal nodular 
hyperplasia (FNH) [10-12], and simple hepatic cyst [13]. For the detection of focal liver lesions, 
DWI performs better than T2 weighted sequences but is generally inferior to T1 weighted dynamic 
gadolinium enhanced (DCE) images [3, 14-16]. Therefore, DWI can be complementary to standard 
MR protocol for imaging focal liver lesion, especially for patients who has renal dysfunction or 
other contraindications to gadolinium based contrast agents.   
The liver is the most common abdominal organ of metastases and liver metastases is the most 
frequently encountered malignant liver lesions [17]. While DWI cannot replace gadolinium 
enhanced sequences [18, 19], it has been found to be beneficial in many ways. Combining DW-
MRI with Gadolinium-EOB-DTPA-enhanced series significantly improved the detection of 
colorectal liver metastases [20, 21]. However, DWI has been reported as being incapable of 
differentiating malignant from benign hepatic solid lesions [22-24]. Although the addition of DWI 
sequences to Gd-EOB-DTPA enhanced MRI may not significantly increase diagnostic accuracy, 
the increase in diagnostic confidence would justify the DWI sequences in a dedicated MRI 
protocol [25]. For instance, appearances of hypointensity on gadoxetic acid-enhanced 
hepatobiliary phase images and hyperintensity on high-b-value DWI may indicate HCC rather than 
regenerative or dysplastic nodules in cirrhotic liver [26]. 
DWI can also serve as a biomarker for treatment response of liver tumor [27, 28]. Several studies 
have reported that the post-trans-arterial chemoembolization (TACE) or post-radiofrequency 
ablation (RFA) ADC values of hepatic malignancies were significantly higher than baseline values 
[29, 30]. With good response to treatment, tumors can exhibit a decline of signal intensity at high 
b-value images or an increase in ADC value, which may be secondary to treatment-induced cystic 
or necrotic changes and cell death [31].  
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Several studies have demonstrated the capability of DWI in early detection and classification of 
liver fibrosis and fatty liver diseases [32-37]. The common theory for studying liver fibrosis by 
DWI is that the interstitial space of fibrotic liver parenchyma may be narrower than normal, which 
is accompanied by restricted diffusion and declined ADC values. A relationship between the 
degree of fibrosis and ADC value was observed. However, using DWI for evaluating liver fibrosis 
still remains controversial [37-39]. An inverse relationship between ADC and hepatic fat fraction 
was documented, although other MRI techniques are better suited for this purpose [40, 41]. 
Conventional DWI was also found helpful in diagnosing parenchymal disorders post liver 
transplant as significant lower ADC was found in patients with at least one parenchymal disorder 
[42]. 
Driven by its increasing clinical applications, there have been significant technical advancements 
in both diffusion-weighted image acquisition and post-processing recently. Such effort has not 
only dramatically improved the image quality of liver DWI, but also offers addition information 
beyond conventional diffusion-weighted images and apparent diffusion constant (ADC) maps. The 
purpose of this article is to provide a comprehensive review of the latest progress in liver DWI 
with emphasis on how conventional DWI should be optimized and performed based results from 
recent studies and what new possibilities beyond conventional DWI are made possible by the 
exciting technical advancements. For conventional liver DWI, a set of optimized basic imaging 
parameters is provided. Along with the analysis of the trade-offs with different imaging options, it 
may server as a reference for clinical implementation. For advanced liver DWI, the remaining 
challenges are discussed so they can be taken into consideration for clinical translation. 
Conventional Diffusion-weighted Imaging and Applications in Liver 
Conventional Diffusion-weighted Imaging (DWI) Technique 
By acquiring images with two or more diffusion weightings and fitting the signal change with a 
mono-exponential decay function, the so called apparent diffusion coefficient (ADC) can be 
estimated. Because of technical challenges, hepatic DWI started around 2005, much later than its 
application in the brain. DWI for liver imaging was reviewed separately by Taouli et al and Kele 
et al in 2010 [43, 44]. This article will focus on the technical developments and the new 
applications since then. 
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Diffusion-weighted Echo-planar Imaging (EPI) 
In order to make MRI signal sensitive to the diffusive motion of water molecules, a diffusion 
encoding module can be added to a MRI pulse sequence. A simple diffusion encoding module 
consists of two large gradient pulses of equal size separated by an 1800 refocusing radio frequency 
(RF) pulse as shown in figure 1. 
The first gradient pulse before the 1800 RF pulse introduces a phase shift which depends on the 
relative spatial location of the water molecule in the direction of the magnetic field gradient. For 
static water proton, such phase shift is fully compensated and recovered by the second gradient 
pulse of equal size after the 1800 refocusing RF pulse. For water molecules that move in the 
direction of the magnetic field gradient during the time interval of those two gradient pulses, the 
phase shift produced by the first gradient may not be fully undone by the second gradient pulses. 
A net phase shift is therefore created by such diffusion sensitizing module. For a large number of 
diffusing water molecules undergoing random Brownian motion, their displacements along the 
diffusion sensitizing direction would be a Gaussian distribution and the sum of their phase shifts 
would be zero. However, the net magnetization, which is the sum of magnetic moments from water 
protons, will be reduced due to their phase differences. The change of magnetization and, 
consequently, MRI signal intensity depends on the diffusivity, or apparent diffusion coefficient 
(ADC), and the amount of diffusion weighting which is quantified as b-value in the following 
equation [45]. 
S/Sb=0 = e – b*ADC          [1] 
where b = 2 G2 2 ( - /3).  
While many acquisition techniques may be used to acquire the diffusion-weighted or encoded 
signal, a fast and efficient acquisition insensitive to bulk motion such as single-shot technique 
would be beneficial. This is because the diffusion sensitizing module itself is relatively long since 
it takes time to play out the large diffusion sensitizing gradient pulses especially when high b-
values are needed and maximum gradient amplitude can be generated by scanner hardware is 
limited.  It is therefore desirable to acquire all the data needed to reconstruct the diffusion-weighted 
image after a single excitation and diffusion sensitizing instead of repeating the diffusion 
sensitizing multiple times, one for each phase encoding steps. Single-shot Echo Planar Imaging 
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(SS-EPI) is a sequence that meets such requirements. Figure 2 shows the sequence diagram of 
diffusion-weighted SS-EPI which diffusion sensitizing in all three orthogonal directions. 
While the water diffusion in the tissue of abdominal and pelvis organs is believed to be mostly 
isotropic, i.e. Dxx = Dyy = Dzz, averaging the diffusion weighting from all three directions, (Dxx + 
Dyy + Dzz)/3, is still beneficial and allows the results to be more consistent and less direction 
dependent. As shown in Figure 2, diffusion sensitizing can be applied in three orthogonal 
directions at the same time without increasing the length of diffusion sensitizing module. 
Acceleration of DWI acquisition  
Like almost any other imaging technique, a fast DWI acquisition is always desirable [46]. With 
the recent advances in phase array coil hardware and reconstruction algorithms, parallel imaging 
is used routinely to accelerate DWI acquisition. Using parallel imaging in diffusion-weighted SS-
EPI has addition advantages beyond reducing the number of k-space lines or the EPI echo train 
length in this case. Because, by reducing the echo train length in DW-SS-EPI sequence, the 
minimal echo time (TE) can also be reduced. A shorter TE also means less T2 decay or a boost in 
signal-to-noise ratio (SNR), which partially offsets the loss of SNR from parallel imaging 
acceleration [46, 47]. Another advantage with shorter echo train length through parallel imaging 
is less geometric distortion. This is important for abdominal DWI as magnetic field inhomogeneity 
is often found at the boundaries of tissue and air due to susceptibility effect. As explained later, 
parallel imaging is also an effective technique for reducing susceptibility artifact. Therefore, it is 
important to take advantage of parallel image if available in DWI protocol in order to achieve 
better results. 
Another promising technique for the acceleration of DWI is through simultaneous multi-slice 
excitation or slice acceleration [48]. In simultaneous multi-slice excitation, a multiband radio-
frequency (RF) pulse excites multiple 2D slices at the same time and the signals from simultaneous 
acquired slices are separated based on the coil sensitivity profile difference in the slice direction. 
Unlike parallel imaging, there can be little or no SNR penalty with slice acceleration. In fact, slice 
acceleration and parallel image can be combined to achieve even higher acceleration factor if the 
design of multiple channel phased array coil supports acceleration in both slice and phase encoding 
directions. The initial application of slice accelerated DWI in liver has produced encouraging 
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results where comparable image quality and ADC values were obtained from both conventional 
DWI and slice accelerated DWI with an acceleration factor of 2 [49, 50]. 
Diffusion weighting with tetrahedral gradients 
In a conventional DWI sequence, orthogonal x, y, and z diffusion gradient pulses are applied 
separately, and isotropic fusion weighted images are obtained by averaging three images with 
orthogonal diffusion sensitizing gradients. However, the orthogonal x, y, and z diffusion gradients 
pulses may be simultaneously applied as shown in figure 3, which shortens the duration of 
diffusion gradient pulses and consequently the TE for the same b-value. Isotropic diffusion-
weighted images can be obtained by using four different tetrahedral vector images [51]. 
Motion compensation 
Although DW-SS-EPI itself is one of fastest acquisition techniques, motion compensation is 
necessary for certain abdominal applications of DWI such as liver for two main reasons. First of 
all, the calculated of ADC requires at least two diffusion-weighted images with different b-values. 
If there is any mis-registration between the two images, there would be an error in the calculated 
ADC map. Secondly, the bulk motion of the tissue during diffusion sensitizing cannot be 
distinguished from actual diffusive motion and therefore causes a bias in the measured ADC. To 
avoid such problem caused by respiratory motion, liver DWI may be acquired with breath-hold 
(BH), respiratory-triggered (RT) or free-breathing (FB) with multiple averages.  
DWI acquisition with breath-hold is quicker than with respiratory-triggered or free-breathing. The 
suspension of respiratory motion and the short acquisition time reduces artifacts due to 
macroscopic physiological motions (respiration, peristalsis). On the other hand, breath-hold is less 
reproducible [52] and one may need to make certain compromises in anatomical coverage due to 
limited number of slices, spatial resolution due to shorter EPI echo train length and signal-to-noise 
ratio (SNR) due to shorter TR in order to fit the entire acquisition in one or multiple breath-holds. 
Respiratory-triggered DWI acquisition requires synchronization with patients’ respiratory cycle 
which can be monitored using a “respiratory” belt or bellow placed around or on the patient’s 
abdomen or with a navigator technique, such as prospective acquisition correction technique 
(PACE) [53], to track the position of patient diaphragm [54] . The acquisition takes place at the 
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end of expiration when motion is minimal. Respiratory-triggered sequences allow for high quality 
images in patients who have difficulty with holding breath, but takes longer scan time. Typical 
acquisition times are 3–6 minutes [43]. Kandpal et al found respiratory-triggered DWI provides 
better image quality and SNR than breath-hold DWI for the evaluation of focal liver lesions 
without any compromise in the calculated ADC values [55]. Despite its advantages, respiratory-
triggered DWI may suffer from pseudo-anisotropy artifact which originates from the complicated 
local hepatic movements, such as extension, contraction and rotation, and causes errors in ADC 
measurement [56]. 
Free-breathing DWI acquisition relies on multiple excitations, which may be necessary anyway to 
achieve adequate SNR, to average out the effect since acquisitions with different b-values or  
repeated acquisition with the same b-value is likely to be from different parts of the respiratory 
cycle [57]. While free-breathing acquisition is time efficient, the image maybe blurred from the 
averaging and the ADC value maybe elevated due to bulk motion [58]. 
Several studies have compared image quality and ADC reproducibility between motion 
compensation techniques. Sandberg et al and Kandpal et al both compared respiratory triggered 
and breath-hold sequences and found better image quality with respiratory triggering [55, 59]. 
Taouli et al evaluated the usefulness of navigator echo triggered diffusion acquisition. They also 
found improvement in image quality and ADC measurement compared with standard breath-hold 
sequences at a cost of longer acquisition time [54]. In contrast, Kwee et al found higher ADC 
values with triggered acquisition [60]. Nasu et al attributed the inaccuracy of ADC measurement 
with respiratory triggering to pseudo-hepatic anisotropy artifact, predominately in the left lobe 
[56]. Such artifact maybe compensated using a larger number of directions in diffusion encoding 
[61]. Nasu et al also compared DWI acquired with free-breathing versus respiratory triggering; 
higher accuracy of ADC measurement was reported using respiratory triggering [62]. Naganawa 
et al compared ADC values obtained with respiratory triggering and free-breathing [63]. They 
found higher ADC values in the right lobe with free-breathing, suggesting that ADC values are 
influenced by respiratory motions. They also found that ADC values in the left lobe are about the 
same in both respiratory triggering and free-breathing, suggesting that ADC in the left lobe is 
mostly influenced by cardiac motion. 
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To reduce impact of cardiac motion, Bruegel et al suggested using pulse triggering [64]. Murtz et 
al also analyzed the influence of cardiac motions on diffusion measurement and found that ADC 
values without cardiac triggering were artificially higher than those obtained with cardiac 
triggering [65]. However, simultaneous use of both respiratory and cardiac triggering makes the 
DWI acquisition extremely long; thus Nasu et al suggested using only respiratory triggering, but 
with more averages to increase the percentage of data acquisition during diastole [56]. Liau et al 
also proposed an improved averaging method to mitigate cardiac motion artifacts in repeat 
measurements [66]. 
Other methods for compensation motion artifacts include the use of velocity compensated 
diffusion gradients [51]. Using dual bipolar gradient waveform, velocity compensated diffusion 
gradients remove all phase sensitivity to constant velocity motion (first-moment) during the 
diffusion-weighting period. The drawbacks of using velocity compensated diffusion gradients is 
that it’s longer that the conventional mono-polar gradients and it does not compensate for higher 
than first moments (e.g. acceleration). 
Artifact Reduction 
While SS-EPI sequence provides efficient image acquisition for DWI, it’s notoriously prone to 
artifacts. The commonly seen artifacts include: chemical shift artifacts, B0 inhomogeneity artifacts 
and Nyquist ghosting artifacts as illustrated in figure 4. 
In EPI sequence, the chemical shift of fat resonance causes a large displacement of fat signal along 
the phase encoding direction. If the fat signal is not completely suppressed, it may super impose 
on the region of interest. Therefore, for DW-EPI in abdomen where fatty tissue is extensively 
present, reliable fat suppression is necessary [1]. Recently, more advanced fat suppression 
techniques based on inversion recovery such as Spectral Pre-saturation with Inversion Recovery 
[SPIR] and SPectral Attenuated Inversion Recovery [SPAIR] have been introduced and integrated 
in DW-EPI. To further improve fat suppression, a new approach of combining Dixon/IDEAL with 
DW-EPI has been attempted and yielded promising results [67, 68]. Lee et al also compared a fat 
suppression technique based on slice-selection gradient reversal [SSGR] with SPIR fat suppression 
at 3T and found SSGR was significantly better than SPIR for liver DWI [69]. 
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Based on a long gradient echo train, the EPI sequence is inherently sensitivity to B0 inhomogeneity 
or magnetic susceptibility artifacts caused by tissue and air interface in the abdominal region, 
especially at higher field such as 3T  [3, 43]. The most effective way to minimize such artifact is 
by reducing the echo train length in EPI. One option is using partial Fourier and parallel imaging 
to reduce the number of phase encoding steps or echoes in EPI as discussed previously. Another 
option is to use high receiver bandwidth and consequently high gradient amplitude to reduce the 
echo spacing. However, with the increase of receiver bandwidth, the SNR will also decrease. 
Therefore, there is a point of diminish return in echo spacing reduction with high receiver 
bandwidth which is scanner hardware dependent. Other than optimizing acquisition parameters, 
one can also reduce the inhomogeneity by improving B0 shim. One of the strategies is to optimize 
the shim one slice at a time (iShim) instead of the entire imaging volume [70]. 
While the mono-polar diffusion sensitizing scheme has the simplest gradient waveform and the 
shortest TE, it’s also less favorable in terms of compensating for eddy current. More sophisticated 
diffusion sensitizing schemes use gradient pulses of different polarity to cancel the eddy currents 
and reduce the artifact. However, because other contributions such as B0 inhomogeneity are more 
prominent in liver application, the improvement from eddy current reduction may not be as 
appreciable and worthy of the increase in both TE and scan time. 
Protocols optimization 
In order to produce high quality ADC map and accurately quantify ADC for regions for interest, 
the first step is to obtain high quality diffusion-weighted images with good SNR and free of 
artifacts. Based on the previous discussions, an optimized DW-SS-EPI for liver should employ a 
robust fat suppression technique to reduce the chemical shift artifact, a combination of parallel 
imaging, partial Fourier and reasonable high receiver bandwidth to minimize the TE and distortion 
artifact and an appropriate scheme to compensate for respiratory motion and cardiac motion if 
necessary. For reference, table 1 lists the typical imaging parameters and options in an optimized 
conventional DWI protocol for liver. 
In addition to optimizing the parameters for DW-EPI acquisition, the choice of b-values is also 
important for DWI. However, the optimal b-values used for liver DWI remain unclear, which 
contributes to the variation of liver ADC reported in the literature. Fundamentally, this is because 
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the diffusive motion of water molecules in liver tissue is not conventional free diffusion. Instead, 
it is mixture of both diffusion and perfusion which will be discussed in more detail later. The 
change of diffusion-weighted signal cannot be modeled with an exponential function as in equation 
1. When the logarithm of diffusion signal change is no longer a linear function of b-value, the 
quantification of ADC becomes b-value dependent. While there is no simple solution due to the 
limitation of the conventional diffusion model, such problem can be partially addressed by using 
b-value in the appropriate range. For conventional DWI of liver, at least a low b-value in the range 
of 0 – 200 s/mm2 and a high b-value in the range of 200 – 1000 s/mm2 should be included. Kaya 
et al recommended using 0 and 800 s/mm2 as two b-values or 0, 50, 600, 800 and 1000 s/mm2 as 
multiple b-values for distinguishing between benign and malignant liver lesions [71]. One factor 
to keep in mind is that the minimum TE of DW-SS-EPI depends on the largest b-value used. 
Choosing a larger maximum b-value will force a longer TE all the acquisition at all b-values which 
will reduce the signal due to T2 decay. 
One can take advantage the variation with b-value to tailor the DWI for certain type of liver lesions. 
DWI with low b-value (20 s/mm2) was reported to demonstrate higher lesion conspicuity of 
hemangiomas and metastases, than single-shot T2 weighted turbo spin echo (T2W SS TSE) [72]. 
DWI using a low b-value (50 s/mm2) was also documented to present a better performance than 
standard breath-hold T2-weighted imaging for focal liver lesion (FLL) detection [14]. DWI with 
high b-values (500 and 1000 s/mm2), on the other hand, could help distinguish hyper-vascular 
pseudo-lesions from HCCs [73]. 
While the dependence of b-values may contributes the observed overlap of ADC values between 
benign and malignant lesions, the similarity of ADC between different pathology could be a more 
fundamental source of limitation for DWI [43], For example, ADC values of solid benign lesions 
such as FNH and adenomas may appear similar to malignant lesions such as metastases and HCC, 
thus limiting the performance of DWI for distinguishing solid liver lesions [22].   
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Advanced Diffusion-weighted Imaging and Applications in Liver 
Despite extensive research in conventional DWI which leads to significant improvement in image 
quality over time, the ADC values derived from conventional DWI have not been found to 
correlate well with the characterization of focal liver masses or the prediction of the degree of 
fibrosis and steatosis. Therefore, more advanced DWI techniques have been developed which 
hopefully can overcome such limitation. 
With the advance in MRI scanner hardware and DWI acquisition strategies, high quality diffusion-
weighted images with large b-value can be obtained within a short time. The improvements in 
motion compensation techniques also allow the extension of DWI acquisition over a longer period. 
Such development makes it possible to perform DWI study with more b-values. By measuring 
diffusion weighting with multiple b-values over a wider range such as those illustrated in figure 5 
and analyzing the data with more sophisticated model, one can not only address the limitation with 
conventional diffusion model, but also to extract additional information about tissue property and 
physiology beyond ADC value. Such advanced DWI techniques include Intra-Voxel Incoherent 
Motion (IVIM), Anomalous Diffusion Imaging (ADI), Diffusion Kurtosis Imaging (DKI) and 
Restriction Spectrum Imaging (RSI). 
Intra-Voxel Incoherent Motion (IVIM) Technique  
IVIM is an advanced DWI technique which acquires diffusion-weighted images with multiple b-
values in order to separate and quantify both fast and slow diffusion components [74]. Instead of 
modeling the attenuation of diffusion-weighted signal with a mono-exponential function, a bi-
exponential function [Equation 2] is used to fit signal intensity dependence on b-value in IVIM as 
illustrated in figure 6. 
S/Sb=0 = (1-PF) e –bD + PF e –bD*        [2]  
In IVIM model, the fast component is typically assumed to be originated from the microvascular 
perfusion while the slow component from free water diffusion. Therefore, fast component is also 
referred to as pseudo perfusion. Hence, the faction of fast diffusion component is referred to as 
perfusion fraction (PF). 
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IVIM model has been used to characterize liver diffusion in multiple studies. Yoon et al compared 
IVIM diffusion versus conventional DWI for the staging of liver fibrosis and found IVIM 
performed better that conventional DWI [34]. Murphy et al demonstrated that liver steatosis and 
fibrosis have significant independent effects on both IVIM diffusivity (D) and perfusion fraction 
(PF) [75]. In Murphy’s study, only three b-values of 0, 100 and 500 s/mm2 where used and IVIM 
parameters were calculated essential from the slope of ln(S/Sb=0) different b-values instead of bi-
exponential fit. Such analysis would inevitably make IVIM result b-value dependent [76, 77]. 
Figure 7 shows IVIM results of three clinical cases with different stages of liver fibrosis. The 
difference in IVIM parameters is consistent with the grade of fibrosis. 
Although IVIM has produced promising results in liver application, the reproducibility of 
measured IVIM diffusivity (D) and perfusion fraction (PF) is relatively poor [78]. This is because 
fitting the bi-exponential function in equation 2 is highly susceptible to noise and error in the 
diffusion weighted images and therefore less robust than fitting the mono-exponential function in 
equation 1. Combination of long acquisition time and poor reproducibility hampers the widespread 
clinical use of IVIM. 
Anomalous Diffusion Imaging (ADI) Technique 
In IVIM model, the diffusive motion is separated into two major components. The slow component 
is often associated with the conventional diffusion while the fast component is associated with a 
transport process in microscopic level such as blood perfusion in the capillaries. Each component 
is still assumed to be conventional diffusion, but with its unique diffusion coefficient. Such model, 
although useful, could be over-simplified. Since water diffusion in tissue is affected by cellular 
and macromolecular structures forming compartments of different scales and barriers of varying 
permeability, there could very well be a continuous spectrum of components with varying 
diffusivity [79]. At the same time, the active transport process from vascular to cellular level is 
also very different and cannot be described with pseudo diffusion of a single diffusion constant. 
The movement of water molecules in such complex environment is no longer the classic Brownian 
motion or normal diffusion where the mean square displacement (MSD), or the amount of space 
that a water molecule can explore, increases linearly with time. Sub-diffusion occurs when the 
diffusion process is altered by obstacles that hinder water molecules from moving away. On the 
other hand, super-diffusion happens when the diffusion process is altered by active transportation 
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which carries water molecules along. The non-linear relationships of MSD versus time for super-
diffusion and sub-diffusion are illustrated in the figure 8. 
Stretched exponential model [Equation 3] was proposed to describe anomalous diffusion in such 
complex and inhomogeneous environment [80, 81]. 
S/ܵ௕ୀ଴ 	ൌ ݁–	ሺ௕∗ୈୈେሻ         [3]  
Where DDC is the distributed diffusion coefficient and , which is limited to 0 and 1, can be 
considered as non-mono-exponential index. When  = 1, the stretched exponential model is the 
same as conventional mono-exponential model and, as  approaches 0, the degree of multiple 
exponential increases as shown in figure 9. Stretched exponential model currently has only been 
used to analyze the liver diffusion data acquired from ex-vivo liver specimens [82]. 
Diffusion Kurtosis Imaging (DKI) Technique 
The conventional diffusion model is based on the assumption that the spatial distribution profile 
of water molecules from diffusion is a Gaussian function. In case of IVIM, there are two Gaussian 
profiles with narrow and wider width, corresponding to the slow and fast diffusion components 
with low and high ADCs. 
In the complex environment of biological tissue, the influence of tissue structure on water diffusion 
cannot be fully described as a simple change in ADC. It also causes the distribution profile to 
deviate from the Gaussian shape. Such non-Gaussianity is called Kurtosis which can be quantified 
as apparent kurtosis coefficient, Kapp [83-85]. At the same time, a kurtosis corrected diffusion 
coefficient, Dapp, can be derived from the Kurtosis model below. 
S/ܵ௕ୀ଴ 	ൌ ݁ି	௕∗஽ೌ೛೛ା	
భ
ల	௕మ∗஽ೌ೛೛మ∗௄ೌ೛೛        [4]  
If Kapp approaches zero, the Kurtosis model becomes the same as conventional diffusion model 
and Dapp = ADC. 
One of the major challenges for DKI is the need to acquire diffusion weighed images with much 
higher b-values in the range of 2000 – 4000 s/mm2. This is because, only at such high b-values, 
the non-Gaussian Kurtosis model starts to deviate away from the Gaussian model, as shown in 
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figure 10. The loss of signal from both diffusion weighting and long TE could makes such 
measurement very time consuming as more signal averaging would be required to produce reliable 
results. 
So far, DKI study of liver is limited due to technical challenges discussed previously. Rosenkrantz 
et al perfomed DKI of ex-vivo liver specimens and found that intermediate-to-substantial excess 
diffusional kurtosis in HCC as well as significant higher corrected diffusion coefficient (Dapp) than 
conventional ADC [86]. More recently, Anderson et al studied the possibility of evaluating liver 
fibrosis with DKI with ex-vivo murine liver specimens at 9.4 T and found significant correlation 
between kurtosis model parameters (Dapp, Kapp) and liver fibrosis [82]. Although DKI has been 
applied in human brain and even prostate studies, there is only one published liver DKI study of 
human subjects to our knowledge [87]. .In this study, the authors measured mean kurtosis (MK) 
of hypervascular hypercelluar carcinoma (HCC) successfully with six b-values of 0 – 2000 s/mm2 
and found that mean kurtosis (MK) performed better than ADC in differentiating viable versus 
non-viable HCC. Unfortunately, no IVIM analysis was done and compared with DKI to determine 
if DKI has any advantage over IVIM. 
Restriction Spectrum Imaging (RSI) Technique 
RSI is a general frame work for modeling advanced diffusion weighted imaging [88].  It assumes 
the acquired signal is a linear combination of a distribution of pools or components of water in the 
tissue with different diffusion characteristics, such as free diffusion, hindered diffusion and 
restricted diffusion. The goal is to determine the relative fraction of each component and as well 
as its diffusion parameters, which are influenced by tissue properties such as cell size, density, 
orientation, etc. In order to accomplish such goal, a wide range of diffusion weighted images with 
varying b-values and diffusion encoding orientations need to be acquired. Such requirement leads 
to the similar challenges in liver imaging application as other advanced DWI techniques discussed 
previously, i.e. its very time consuming. Therefore, RSI is so far only limited to brain and prostate 
applications.    
Number and distribution of b-values 
For advanced DWI techniques that acquires data of multiple b-values, choice of the number of b-
values as well as their range and distribution becomes an important issues. While more data points 
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with different b-values allow better sampling of the diffusion signal model, it also increases the 
acquisition time. Such trade-off is application dependent and should be carefully considered. The 
number of b-values ranging from 7 to 20 is typically used for abdominal imaging studies. Although 
the fewer b-values tend to increase the error of the estimated IVIM parameters, it was reported that 
liver IVIM with as few as 4 b-values did not substantially compromise the precision and 
reproducibility of IVIM parameters compared to the acquisition of 16 b-values [89]. Given the 
constraint from the number of b-values, the range and distribution should also be carefully 
considered to make the modeling more robust. Take the two-step approach for example, several 
high b-values should be included to reliably determine the D or Dslow parameter and several low 
b-values should be include to be sensitive to the influence of D* or Dfast component. 
Multi-shot High-resolution Liver DWI Technique 
In order to avoid motion-related artifacts, liver DWI is typically acquired with SS-EPI as discussed 
previously. SS-EPI based DWI protocols, however, does have some limitations, including limited 
spatial resolution; and SNR penalty due to long EPI echo train. Such limitations inevitably 
compromise the image quality of liver DWI and make it more challenging to detect subtle lesions 
with DW-SS-EPI. Recently, there have been some attempts to high resolution liver DWI with 
multi-shot or segmented EPI. 
Tokoro et al used the so called readout-segment EPI (RESOLVE) which divides the k-space into 
multiple segments with the same number of phase encoding but fewer data points in readout 
direction [90]. A 2D navigator echo is re-acquired with each segment to detect and correct phase 
changes between multiple segments. They found FB RESOVLE causes fewer artifacts and allows 
comparable lesion detectability versus RT DW-SS-EPI with shorter scan time [91]. 
More recently, Chang et al applied another multi-shot technique called multiplexed sensitivity 
encoded (MUSE) and combined it with either navigator-based respiratory-gating or breath hold 
for liver DWI [92]. The more anatomical details could be visualized in multi-shot MUSE DWI 
[93]. 
Advanced DWI Post-processing and Analysis 
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There are several different approaches for fitting the bi-exponential function to IVIM. One-step 
approach uses all the data points with different b-values in order to find the best fit. However, due 
to the larger degree of freedom, the search may ends up in a local rather than a global minimum of 
the parameter space, especially of the initial condition has a large deviation. Such error is more 
likely to occur when the quality of data is suboptimal, i.e. compromised by noise or artifacts. 
Therefore, a two-step approach is now commonly used. 
With two-step approach, the data points with relatively higher b-value (b => 200s/mm2) is fitted 
with a mono-exponential function first to determine the D or Dslow. Then, the D or Dslow parameter 
is fixed or locked when fitting all the data points with the bi-exponential function. While two-step 
approach is shown to improve the stability of fitting, it will also unavoidably introduce biases in 
the results. 
Texture and Histogram Analysis  
Another idea of extracting information related to tissue diffusion properties for diagnosis and 
evaluation is through texture or histogram analysis. With texture analysis, a set of metrics 
characterizing the perceived texture of an image is calculated. With histogram analysis, the 
heterogeneity or the distribution of image intensity within a region of interest is evaluated. While 
both texture and histogram analysis can be applied to the results of liver DWI such as the ADC 
map, the discussion of the methods of texture and histogram analysis is beyond the scope of this 
review. Barry et al applied texture analysis to the ex-vivo murine liver ADC map and found 
moderate to very strong correlation between texture features and liver fibrosis [94]. Lambregts et 
al performed histogram analysis of ADC values of the whole liver parenchyma, excluding focal 
lesions, in patients with proven colorectal liver metastases and found a significant difference in 
fifth percentile and standard deviation compared with healthy controls without liver disease [95]. 
Such results suggest that the changes in liver microarchitecture and diffusion properties may occur 
not only at the site of focal metastatic lesions visible on imaging but also in the liver parenchyma 
that appears to be free from tumor on MRI.  
Discussion and Conclusions 
Conventional DWI provides useful diagnostic information in liver imaging. The images can be 
acquired within a short amount time for two to three b-values even with respiratory triggering. The 
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artifact can be minimized with latest fat suppression techniques and optimized EPI acquisition 
parameters even at 3T. The calculation of ADC is straight forward and is ready available as part 
of the software on the scanner console. Therefore, conventional DWI has been widely integrated 
in routine clinical imaging of the liver. 
Despite the success of conventional diffusion-weighted imaging and its clinical application, 
diffusion-weighted imaging is continuing to advance rapidly. The improvement of scanner 
performance and acquisition techniques provides high quality DWI images and allows more 
sophisticated models to be used to analyze DWI data. Such model can potentially better 
characterize water diffusion in the complicated in-vivo environment and the addition diffusion 
parameters beyond the conventional ADC maybe more sensitive to physiological changes in the 
disease process and therefore of value for clinical diagnosis. However, there are two major 
technical challenges with the advanced DWI of the liver. One of them is due to the requirement of 
more images with incrementing b-values and also images with high b-values (b > 1000s/mm2) 
where more signal averaging is needed to compensate for low SNR. Such requirement prolongs 
the acquisition time of advanced DWI of liver. Because of the long scan time, clinical efficiency 
and patient cooperation becomes the obstacle for its routine use. Although higher field strength 
such as 3.0T offers greater SNR, its advantage in liver DWI over 1.5T is limited. This is because 
EPI acquisition is sensitive to the local magnetic field inhomogeneity which also increases with 
field strength. In order to reduce the artifacts resulting from local magnetic field inhomogeneity, 
certain adjustments in the imaging parameters need to be made which also compromises the SNR 
gain from 3.0T. Therefore, new technical advances to accelerate the DWI acquisition such as 
simultaneous multiple slice imaging is holds greater promise in making advanced DWI of liver 
clinically feasible. Another challenge is the choice of an appropriate model and the understanding 
of the physiological basis or justification for such model. Except for IVIM, the appropriateness of 
other advanced DWI models for liver application remains to be investigated. At this stage, the 
modeling of advanced DWI is typically done offline with software tools developed in individual 
research labs. Overall, there has been limited experience of these advanced DWI technique and its 
application in liver that the optimized protocols and standard post-processing are not established. 
Further studies are needed to carefully compare different techniques and to evaluate their benefits 
and value in clinical diagnosis.   
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Figure 1: Diffusion sensitizing module with Stejskal-Tanner diffusion scheme where two mono-polar 
gradient pulses are separated by an 1800 refocusing RF pulse. The degree of diffusion weighting depends 
on the amplitude (G) and width () of gradient pulses as well as the separation or delay () between the two 
gradient pluses. 
 
Figure 2: DW-SS-EPI pulse sequence where single-shot EPI acquisition is preceded by a slice selective 
excitation of 900 flip angle and a diffusion weighting module discussed previously. 
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Figure 3. Orthogonal and tetrahedral diffusion weighting. In orthogonal diffusion weighting, the diffusion 
sensitizing gradients are turned on for one direction at a time to produce diffusion weighting vectors of 
(1,0,0), (0,1,0) and (0,0,1). In tetrahedral diffusion weighting, the diffusion sensitizing gradients in all three 
directions are turned on at same time to produce diffusion weighting vectors of (1,-1,-1), (-1,1,-1) , (1,1,1)  
and (-1,-1,1). With tetrahedral diffusion weighting, the amplitude of effective diffusion weighting gradient 
is √3 (~ 1.73) times greater than orthogonal diffusion weighting under the same gradient performance. 
 
Figure 4: Chemical shift, N/2 or Nyquist ghosting and geometric distortion artifacts are commonly observed 
with DW-SS-EPI in liver application. The because of chemical shift the signal from fat, if not completely 
suppressed, can form a band of interference over the liver. Nyquist ghosting can cause a fraction of the liver 
signal to be shifted half FOV in the phase encoding direction over overlay on the correct image. The 
geometric distortion can cause signal pile up in certain areas. It also makes correlating DWI images with 
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other types of images more challenging. All of these artifacts will compromise quality of diffusion weighed 
images and introduce error in the quantification. 
 
Figure 5. Typical liver IVIM DWI images with six different b-values of 0 – 600 s/mm2 acquired with 
respiratory triggering at 1.5T. 
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Figure 6. IVIM diffusion model of PF = 0.25; D*=0.01 and PF = 0.5; D*=0.01 versus conventional diffusion 
model of PF = 0. With the increase of perfusion fraction (PF), the attenuation of diffusion weighted signal 
with respect to b-value in IVIM models deviates from the conventional diffusion model (the straight blue 
line) mostly in the low b-value range. 
 
Figure 7. Plots of relative signal intensity at different b-values (signal at b=0 s/mm2 is 1) in y-axis versus 
b-values on x-axis for different patients. A. 61-year-old male with elevated liver function and no biopsy 
evidence of liver fibrosis (F0). Note the high D, D* and PF values indicating relatively unhampered 
diffusion and perfusion. B. 51-year-old male with hepatitis B and found to have F1 fibrosis on biopsy. Note 
the reduction in D, D* and PF compared to patient A. C. 54-year-old male with clinically established 
cirrhosis and biopsy finding of F4. Note that D, D* and PF values are the lowest in this patient. In general 
IVIM parameters, especially D*, have been shown to correlate well with grades of liver fibrosis. 
  
Figure 8. Anomalous diffusion, e.g. super-diffusion (red curve) and sub-diffusion (blue curve), versus 
conventional or normal diffusion (straight green line).  In anomalous diffusion, the mean square distance 
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(MSD) of diffusive motion is not proportional to the diffusion time. In case of super-diffusion, the MSD 
increases faster than linear due to transport processes such as perfusion. In case of sub-diffusion, the MSD 
increases slower than linear due to barriers such as cellular structure or macro-molecules. In the complex 
micro environment of liver tissue, there is a mixture of super-diffusion, normal diffusion and sub-diffusion. 
The relative amount of each type of diffusion process may be altered by pathology while the ADC remains 
unchanged. 
 
Figure 9. Stretched exponential models of  = 0.75 and  = 0.5 versus conventional diffusion model of  
= 1.0. Stretched exponential is one of the models to describe the attenuation of diffusion weighted signal 
with respected to b-value when there is a mixture of super-diffusion, normal diffusion and sub-diffusion. 
However, the signal attenuation curves of stretched exponential models with different  values can cross 
each other at a given b-value, which is 1000 s/mm2 in this example. That means the ADC value would be 
the same if measured with b = 0 and 1000 s/mm2 although the composition of different types of diffusion 
processes is different. 
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Figure 10. Diffusion kurtosis model of Kapp = 1.0 and Kapp = 0.5 versus conventional diffusion model of 
Kapp = 0. A deviation of Kapp from zero suggests that the water diffusion is hindered by the tissue structure 
and a change in Kapp is an indication of tissue structural change which could be pathological. Most of the 
deviation of diffusion kurtosis model from convention diffusion is in the high b-value range, opposite of 
the IVIM model where most of deviation is in the low b-value range. 
